Evidence map›Paper›PMID 38258062›Full record

ArticlePharmaceutics2023

Effect of Phase-Change Nanodroplets and Ultrasound on Blood-Brain Barrier Permeability In Vitro.

Stavros Vlatakis, Weiqi Zhang, Sarah Thomas, Paul Cressey, Alexandru Corneliu Moldovan, Hilde Metzger, Paul Prentice, Sandy Cochran, Maya Thanou

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Stavros VlatakisInstitute of Pharmaceutical Science, King's College London, London SE1 9NH, UK.ORCID 0000-0002-8005-6105
Weiqi ZhangInstitute of Pharmaceutical Science, King's College London, London SE1 9NH, UK.ORCID 0000-0001-5880-0332
Sarah ThomasInstitute of Pharmaceutical Science, King's College London, London SE1 9NH, UK.
Paul CresseyInstitute of Pharmaceutical Science, King's College London, London SE1 9NH, UK.
Alexandru Corneliu MoldovanJames Watt School of Engineering, University of Glasgow, Glasgow G12 8QQ, UK.
Hilde MetzgerJames Watt School of Engineering, University of Glasgow, Glasgow G12 8QQ, UK.ORCID 0000-0003-2662-4690
Paul PrenticeJames Watt School of Engineering, University of Glasgow, Glasgow G12 8QQ, UK.ORCID 0000-0003-2228-3622
Sandy CochranJames Watt School of Engineering, University of Glasgow, Glasgow G12 8QQ, UK.ORCID 0000-0001-7324-7790
Maya ThanouInstitute of Pharmaceutical Science, King's College London, London SE1 9NH, UK.ORCID 0000-0002-7038-0323
King's College London · GBUniversity of Glasgow · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phase-change nanodroplets (PCND;NDs) are emulsions with a perfluorocarbon (PFC) core that undergo acoustic vaporisation as a response to ultrasound (US). Nanodroplets change to microbubbles and cavitate while under the effect of US. This cavitation can apply forces on cell connections in biological barrier membranes, such as the blood-brain barrier (BBB), and trigger a transient and reversible increased permeability to molecules and matter. This study aims to present the preparation of lipid-based NDs and investigate their effects on the brain endothelial cell barrier in vitro. The NDs were prepared using the thin-film hydration method, followed by the PFC addition. They were characterised for size, cavitation (using a high-speed camera), and PFC encapsulation (using FTIR). The bEnd.3 (mouse brain endothelial) cells were seeded onto transwell inserts. Fluorescein with NDs and/or microbubbles were applied on the bEND3 cells and the effect of US on fluorescein permeability was measured. The Live/Dead assay was used to assess the BBB integrity after the treatments. Size and PFC content analysis indicated that the NDs were stable while stored. High-speed camera imaging confirmed that the NDs cavitate after US exposure of 0.12 MPa. The BBB cell model experiments revealed a 4-fold increase in cell membrane permeation after the combined application of US and NDs. The Live/Dead assay results indicated damage to the BBB membrane integrity, but this damage was less when compared to the one caused by microbubbles. This in vitro study shows that nanodroplets have the potential to cause BBB opening in a similar manner to microbubbles. Both cavitation agents caused damage on the endothelial cells. It appears that NDs cause less cell damage compared to microbubbles.

Indexed as

blood-brain barrierdrug deliverynanodropletspermeabilityultrasound

Identifiers

PMID38258062
PMCPMC10818572
OpenAlexW4390338505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.